Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 90 entries
Sorted by: Best Match Show Resources per page
Screening for Disruptive Behaviour Problems in Preschool Children in Primary Health Care Settings.

Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent

Charach A, McLennan JD, Bélanger SA, Nixon MK.
PMID: 29056978
J Can Acad Child Adolesc Psychiatry. 2017;26(3):172-178. Epub 2017 Oct 01.

Disruptive behaviour problems in preschool children are significant risk factors for, and potential components of, neurodevelopmental and mental health disorders. Some non-compliance, temper tantrums and aggression between two and five years of age are normal and transient. However, problematic...

Cite
Charach A, McLennan JD, Bélanger SA, et al. Screening for Disruptive Behaviour Problems in Preschool Children in Primary Health Care Settings. J Can Acad Child Adolesc Psychiatry. 2017;26(3):172-178
Charach, A., McLennan, J. D., Bélanger, S. A., & Nixon, M. K. (2017). Screening for Disruptive Behaviour Problems in Preschool Children in Primary Health Care Settings. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent, 26(3), 172-178.
Charach, Alice, et al. "Screening for Disruptive Behaviour Problems in Preschool Children in Primary Health Care Settings." Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent vol. 26,3 (2017): 172-178.
Charach A, McLennan JD, Bélanger SA, Nixon MK. Screening for Disruptive Behaviour Problems in Preschool Children in Primary Health Care Settings. J Can Acad Child Adolesc Psychiatry. 2017;26(3):172-178. Epub 2017 Oct 01. PMID: 29056978; PMCID: PMC5642455.
Copy Download .nbib Format: NLM
Ecthyma gangrenosum secondary to methicillin-sensitive .

International journal of women's dermatology

Ivanaviciene J, Chirch L, Grant-Kels JM, Kerr PE, Finch J.
PMID: 28492017
Int J Womens Dermatol. 2016 Jul 22;2(3):89-92. doi: 10.1016/j.ijwd.2016.05.004. eCollection 2016 Sep.

Ecthyma gangrenosum (EG) is a well-described skin manifestation of

Cite
Ivanaviciene J, Chirch L, Grant-Kels JM, et al. Ecthyma gangrenosum secondary to methicillin-sensitive . Int J Womens Dermatol. 2016;2(3):89-92doi: 10.1016/j.ijwd.2016.05.004.
Ivanaviciene, J., Chirch, L., Grant-Kels, J. M., Kerr, P. E., & Finch, J. (2016). Ecthyma gangrenosum secondary to methicillin-sensitive . International journal of women's dermatology, 2(3), 89-92. https://doi.org/10.1016/j.ijwd.2016.05.004
Ivanaviciene, Jurate, et al. "Ecthyma gangrenosum secondary to methicillin-sensitive ." International journal of women's dermatology vol. 2,3 (2016): 89-92. doi: https://doi.org/10.1016/j.ijwd.2016.05.004
Ivanaviciene J, Chirch L, Grant-Kels JM, Kerr PE, Finch J. Ecthyma gangrenosum secondary to methicillin-sensitive . Int J Womens Dermatol. 2016 Jul 22;2(3):89-92. doi: 10.1016/j.ijwd.2016.05.004. eCollection 2016 Sep. PMID: 28492017; PMCID: PMC5418883.
Copy Download .nbib Format: NLM
HLBT-100: a highly potent anti-cancer flavanone from .

Cancer cell international

Lowe HIC, Toyang NJ, Watson CT, Ayeah KN, Bryant J.
PMID: 28286420
Cancer Cell Int. 2017 Mar 07;17:38. doi: 10.1186/s12935-017-0404-z. eCollection 2017.

BACKGROUND: The incidence and mortalities from cancers remain on the rise worldwide. Despite significant efforts to discover and develop novel anticancer agents, many cancers remain in the unmet need category. As such, efforts to discover and develop new and...

Cite
Lowe HIC, Toyang NJ, Watson CT, et al. HLBT-100: a highly potent anti-cancer flavanone from . Cancer Cell Int. 2017;17:38doi: 10.1186/s12935-017-0404-z.
Lowe, H. I. C., Toyang, N. J., Watson, C. T., Ayeah, K. N., & Bryant, J. (2017). HLBT-100: a highly potent anti-cancer flavanone from . Cancer cell international, 1738. https://doi.org/10.1186/s12935-017-0404-z
Lowe, Henry I C, et al. "HLBT-100: a highly potent anti-cancer flavanone from ." Cancer cell international vol. 17 (2017): 38. doi: https://doi.org/10.1186/s12935-017-0404-z
Lowe HIC, Toyang NJ, Watson CT, Ayeah KN, Bryant J. HLBT-100: a highly potent anti-cancer flavanone from . Cancer Cell Int. 2017 Mar 07;17:38. doi: 10.1186/s12935-017-0404-z. eCollection 2017. PMID: 28286420; PMCID: PMC5341182.
Copy Download .nbib Format: NLM
[Clinico-social considerations on patients in the tuberculous environment].

Prensa medica argentina

CORACH L.
PMID: 13155414
Prensa Med Argent. 1954 Feb 26;41(9):591-5.

No abstract available.

Cite
CORACH L. Consideraciones clänicosociàles sobre enfermos descubiertos en el medio tuberculoso. [Clinico-social considerations on patients in the tuberculous environment]. Prensa Med Argent. 1954;41(9):591-5
CORACH, L. (1954). Consideraciones clänicosociàles sobre enfermos descubiertos en el medio tuberculoso. [Clinico-social considerations on patients in the tuberculous environment]. Prensa medica argentina, 41(9), 591-5.
CORACH, L. "Consideraciones clänicosociàles sobre enfermos descubiertos en el medio tuberculoso." [Clinico-social considerations on patients in the tuberculous environment]. Prensa medica argentina vol. 41,9 (1954): 591-5.
CORACH L. Consideraciones clänicosociàles sobre enfermos descubiertos en el medio tuberculoso. [Clinico-social considerations on patients in the tuberculous environment]. Prensa Med Argent. 1954 Feb 26;41(9):591-5. Undetermined. PMID: 13155414.
Copy Download .nbib Format: NLM
Chondrosarcomas of the petrous apex.

Skull base surgery

Charachon R, Gratacap B, Lavieille JP.
PMID: 17170862
Skull Base Surg. 1992;2(3):171-5. doi: 10.1055/s-2008-1057130.

From 1974 to 1988, four patients with chondrosarcomas of the petrous apex were followed. Average age was 46 years (range, 30 to 61), one man and three women. The mean delay between the first patient's symptoms and the visit...

Cite
Charachon R, Gratacap B, Lavieille JP. Chondrosarcomas of the petrous apex. Skull Base Surg. 1992;2(3):171-5doi: 10.1055/s-2008-1057130.
Charachon, R., Gratacap, B., & Lavieille, J. P. (1992). Chondrosarcomas of the petrous apex. Skull base surgery, 2(3), 171-5. https://doi.org/10.1055/s-2008-1057130
Charachon, R, et al. "Chondrosarcomas of the petrous apex." Skull base surgery vol. 2,3 (1992): 171-5. doi: https://doi.org/10.1055/s-2008-1057130
Charachon R, Gratacap B, Lavieille JP. Chondrosarcomas of the petrous apex. Skull Base Surg. 1992;2(3):171-5. doi: 10.1055/s-2008-1057130. PMID: 17170862; PMCID: PMC1656370.
Copy Download .nbib Format: NLM
Using stimulant medication for children with ADHD: what do parents say? A brief report.

Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent

Charach A, Skyba A, Cook L, Antle BJ.
PMID: 18392197
J Can Acad Child Adolesc Psychiatry. 2006 May;15(2):75-83.

INTRODUCTION: Long-term adherence to stimulant treatment for Attention Deficit Hyperactivity Disorder (ADHD) is frequently poor. Since parents are the key decision makers regarding their child's health care, their thoughts regarding medication use are crucial to whether children take prescribed...

Cite
Charach A, Skyba A, Cook L, et al. Using stimulant medication for children with ADHD: what do parents say? A brief report. J Can Acad Child Adolesc Psychiatry. 2006;15(2):75-83
Charach, A., Skyba, A., Cook, L., & Antle, B. J. (2006). Using stimulant medication for children with ADHD: what do parents say? A brief report. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent, 15(2), 75-83.
Charach, Alice, et al. "Using stimulant medication for children with ADHD: what do parents say? A brief report." Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent vol. 15,2 (2006): 75-83.
Charach A, Skyba A, Cook L, Antle BJ. Using stimulant medication for children with ADHD: what do parents say? A brief report. J Can Acad Child Adolesc Psychiatry. 2006 May;15(2):75-83. PMID: 18392197; PMCID: PMC2277288.
Copy Download .nbib Format: NLM
Hodgkin's disease in children.

New York state journal of medicine

CHARACHE H.
PMID: 21016475
N Y State J Med. 1946 Mar 01;46:507-9.

No abstract available.

Cite
CHARACHE H. Hodgkin's disease in children. N Y State J Med. 1946;46:507-9
CHARACHE, H. (1946). Hodgkin's disease in children. New York state journal of medicine, 46507-9.
CHARACHE, H. "Hodgkin's disease in children." New York state journal of medicine vol. 46 (1946): 507-9.
CHARACHE H. Hodgkin's disease in children. N Y State J Med. 1946 Mar 01;46:507-9. PMID: 21016475.
Copy Download .nbib Format: NLM
Anti-oxidized low-density lipoprotein antibodies in chronic heart failure.

World journal of cardiology

Charach G, Rabinovich A, Argov O, Weintraub M, Charach L, Ayzenberg O, George J.
PMID: 23185651
World J Cardiol. 2012 Nov 26;4(11):302-8. doi: 10.4330/wjc.v4.i11.302.

Oxidative stress may play a significant role in the pathogenesis of heart failure (HF). Antibodies to oxidized low-density lipoprotein (oxLDL Abs) reflect an immune response to LDL over a prolonged period and may represent long-term oxidative stress in HF....

Cite
Charach G, Rabinovich A, Argov O, et al. Anti-oxidized low-density lipoprotein antibodies in chronic heart failure. World J Cardiol. 2012;4(11):302-8doi: 10.4330/wjc.v4.i11.302.
Charach, G., Rabinovich, A., Argov, O., Weintraub, M., Charach, L., Ayzenberg, O., & George, J. (2012). Anti-oxidized low-density lipoprotein antibodies in chronic heart failure. World journal of cardiology, 4(11), 302-8. https://doi.org/10.4330/wjc.v4.i11.302
Charach, Gideon, et al. "Anti-oxidized low-density lipoprotein antibodies in chronic heart failure." World journal of cardiology vol. 4,11 (2012): 302-8. doi: https://doi.org/10.4330/wjc.v4.i11.302
Charach G, Rabinovich A, Argov O, Weintraub M, Charach L, Ayzenberg O, George J. Anti-oxidized low-density lipoprotein antibodies in chronic heart failure. World J Cardiol. 2012 Nov 26;4(11):302-8. doi: 10.4330/wjc.v4.i11.302. PMID: 23185651; PMCID: PMC3505849.
Copy Download .nbib Format: NLM
New primary ipsilateral metachronous breast tumor: a case report.

Case reports in oncology

Cuerda S, Ramírez N, Chara L, Cassinello J.
PMID: 23185163
Case Rep Oncol. 2012 Sep;5(3):580-5. doi: 10.1159/000345042. Epub 2012 Oct 30.

After breast-conserving treatment, the occurrence of ipsilateral breast tumor relapse raises the concern regarding whether it may represent two distinct types of lesion that it is important to define, a true recurrence (TR) or a new primary tumor (NPT)....

Cite
Cuerda S, Ramírez N, Chara L, et al. New primary ipsilateral metachronous breast tumor: a case report. Case Rep Oncol. 2012;5(3):580-5doi: 10.1159/000345042.
Cuerda, S., Ramírez, N., Chara, L., & Cassinello, J. (2012). New primary ipsilateral metachronous breast tumor: a case report. Case reports in oncology, 5(3), 580-5. https://doi.org/10.1159/000345042
Cuerda, Silvia, et al. "New primary ipsilateral metachronous breast tumor: a case report." Case reports in oncology vol. 5,3 (2012): 580-5. doi: https://doi.org/10.1159/000345042
Cuerda S, Ramírez N, Chara L, Cassinello J. New primary ipsilateral metachronous breast tumor: a case report. Case Rep Oncol. 2012 Sep;5(3):580-5. doi: 10.1159/000345042. Epub 2012 Oct 30. PMID: 23185163; PMCID: PMC3506040.
Copy Download .nbib Format: NLM
Management of Infected Total Knee Arthroplasty by a New Innovative Customized Articulating Knee Spacer: An Early Experience.

Journal of orthopaedic case reports

Marothi DP, Sharma V, Sheth AN, Shah VI, Bharath L, Pachore JA.
PMID: 28164047
J Orthop Case Rep. 2016 Sep-Oct;6(4):20-22. doi: 10.13107/jocr.2250-0685.552.

INTRODUCTION: Management of infected total knee arthroplasty (TKA) is a challenge to patient and surgeon alike. Two-stage exchange is the universally acclaimed method to tackle this problem. Various spacer devices are available for the first stage surgery for local...

Cite
Marothi DP, Sharma V, Sheth AN, et al. Management of Infected Total Knee Arthroplasty by a New Innovative Customized Articulating Knee Spacer: An Early Experience. J Orthop Case Rep. 2016;6(4):20-22doi: 10.13107/jocr.2250-0685.552.
Marothi, D. P., Sharma, V., Sheth, A. N., Shah, V. I., Bharath, L., & Pachore, J. A. (2016). Management of Infected Total Knee Arthroplasty by a New Innovative Customized Articulating Knee Spacer: An Early Experience. Journal of orthopaedic case reports, 6(4), 20-22. https://doi.org/10.13107/jocr.2250-0685.552
Marothi, Dhiraj P, et al. "Management of Infected Total Knee Arthroplasty by a New Innovative Customized Articulating Knee Spacer: An Early Experience." Journal of orthopaedic case reports vol. 6,4 (2016): 20-22. doi: https://doi.org/10.13107/jocr.2250-0685.552
Marothi DP, Sharma V, Sheth AN, Shah VI, Bharath L, Pachore JA. Management of Infected Total Knee Arthroplasty by a New Innovative Customized Articulating Knee Spacer: An Early Experience. J Orthop Case Rep. 2016 Sep-Oct;6(4):20-22. doi: 10.13107/jocr.2250-0685.552. PMID: 28164047; PMCID: PMC5288616.
Copy Download .nbib Format: NLM
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota.

Scientific reports

Harach T, Marungruang N, Duthilleul N, Cheatham V, Mc Coy KD, Frisoni G, Neher JJ, Fåk F, Jucker M, Lasser T, Bolmont T.
PMID: 28176819
Sci Rep. 2017 Feb 08;7:41802. doi: 10.1038/srep41802.

Alzheimer's disease is the most common form of dementia in the western world, however there is no cure available for this devastating neurodegenerative disorder. Despite clinical and experimental evidence implicating the intestinal microbiota in a number of brain disorders,...

Cite
Harach T, Marungruang N, Duthilleul N, et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep. 2017;7:41802doi: 10.1038/srep41802.
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., & Bolmont, T. (2017). Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Scientific reports, 741802. https://doi.org/10.1038/srep41802
Harach, T, et al. "Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota." Scientific reports vol. 7 (2017): 41802. doi: https://doi.org/10.1038/srep41802
Harach T, Marungruang N, Duthilleul N, Cheatham V, Mc Coy KD, Frisoni G, Neher JJ, Fåk F, Jucker M, Lasser T, Bolmont T. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci Rep. 2017 Feb 08;7:41802. doi: 10.1038/srep41802. PMID: 28176819; PMCID: PMC5297247.
Copy Download .nbib Format: NLM
Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab.

Central-European journal of immunology

Vilaiyuk S, Lerkvaleekul B, Soponkanaporn S, Setthaudom C, Buranapraditkun S.
PMID: 31530985
Cent Eur J Immunol. 2019;44(2):150-158. doi: 10.5114/ceji.2019.87066. Epub 2019 Jul 30.

INTRODUCTION: Interleukin (IL)-6 is a proinflammatory cytokine involved in systemic juvenile idiopathic arthritis (SJIA). Since these patients are often treated with tocilizumab (TCZ), anti-IL-6 receptor (IL-6R) antibody, we investigated correlations between serum IL-6 and soluble IL-6R-levels and disease activity...

Cite
Vilaiyuk S, Lerkvaleekul B, Soponkanaporn S, et al. Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab. Cent Eur J Immunol. 2019;44(2):150-158doi: 10.5114/ceji.2019.87066.
Vilaiyuk, S., Lerkvaleekul, B., Soponkanaporn, S., Setthaudom, C., & Buranapraditkun, S. (2019). Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab. Central-European journal of immunology, 44(2), 150-158. https://doi.org/10.5114/ceji.2019.87066
Vilaiyuk, Soamarat, et al. "Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab." Central-European journal of immunology vol. 44,2 (2019): 150-158. doi: https://doi.org/10.5114/ceji.2019.87066
Vilaiyuk S, Lerkvaleekul B, Soponkanaporn S, Setthaudom C, Buranapraditkun S. Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab. Cent Eur J Immunol. 2019;44(2):150-158. doi: 10.5114/ceji.2019.87066. Epub 2019 Jul 30. PMID: 31530985; PMCID: PMC6745541.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 90 entries